Review
doi: 10.1002/humu.1132.
Transthyretin mutations in hyperthyroxinemia and amyloid diseases
Affiliations
- PMID: 11385707
- DOI: 10.1002/humu.1132
Item in Clipboard
Review
Transthyretin mutations in hyperthyroxinemia and amyloid diseases
Hum Mutat.
2001 Jun.
Abstract
Over 80 different disease-causing mutations in transthyretin (TTR) have been reported. The vast majority are inherited in an autosomal dominant manner and are related to amyloid deposition, affecting predominantly peripheral nerve and/or the heart. A small portion of TTR mutations are apparently non-amyloidogenic. Among these are mutations responsible for hyperthyroxinemia, presenting high affinity for thyroxine (a TTR ligand). Compound heterozygotic individuals for TTR mutants have been described; noteworthy is the clinically protective effect exerted by a non-pathogenic over a pathogenic mutation. Current TTR mutations and their significance are briefly reviewed here.
Copyright 2001 Wiley-Liss, Inc.
Similar articles
-
[Thyroxine-binding proteins--familial euthyroid hyperthyroxinemia due to point mutations of transthyretin].Nihon Rinsho. 1994 Apr;52(4):886-9. Nihon Rinsho. 1994. PMID: 8196175 Review. Japanese.
-
Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin.Biochem Biophys Res Commun. 2000 Aug 11;274(3):702-6. doi: 10.1006/bbrc.2000.3203. Biochem Biophys Res Commun. 2000. PMID: 10924339
-
Comparative studies of two transthyretin variants with protective effects on familial amyloidotic polyneuropathy: TTR R104H and TTR T119M.Biochem Biophys Res Commun. 2000 Apr 21;270(3):1024-8. doi: 10.1006/bbrc.2000.2554. Biochem Biophys Res Commun. 2000. PMID: 10772944
-
Different disease-causing mutations in transthyretin trigger the same conformational conversion.Protein Eng Des Sel. 2008 Mar;21(3):187-95. doi: 10.1093/protein/gzm086. Epub 2008 Feb 13. Protein Eng Des Sel. 2008. PMID: 18276611
-
The molecular biology and clinical features of amyloid neuropathy.Muscle Nerve. 2007 Oct;36(4):411-23. doi: 10.1002/mus.20821. Muscle Nerve. 2007. PMID: 17554795 Review.
Cited by
-
Serum transthyretin monomer as a possible marker of blood-to-CSF barrier disruption.J Neurosci. 2003 Mar 1;23(5):1949-55. doi: 10.1523/JNEUROSCI.23-05-01949.2003. J Neurosci. 2003. PMID: 12629200 Free PMC article. Clinical Trial.
-
Evidence for early cytotoxic aggregates in transgenic mice for human transthyretin Leu55Pro.Am J Pathol. 2002 Nov;161(5):1935-48. doi: 10.1016/S0002-9440(10)64469-0. Am J Pathol. 2002. PMID: 12414539 Free PMC article.
-
Pauling and Corey's alpha-pleated sheet structure may define the prefibrillar amyloidogenic intermediate in amyloid disease.Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11622-7. doi: 10.1073/pnas.0401781101. Epub 2004 Jul 27. Proc Natl Acad Sci U S A. 2004. PMID: 15280548 Free PMC article.
-
Peptides Composed of Alternating L- and D-Amino Acids Inhibit Amyloidogenesis in Three Distinct Amyloid Systems Independent of Sequence.J Mol Biol. 2016 Jun 5;428(11):2317-2328. doi: 10.1016/j.jmb.2016.03.013. Epub 2016 Mar 21. J Mol Biol. 2016. PMID: 27012425 Free PMC article.
-
Progress in transthyretin fibrillogenesis research strengthens the amyloid hypothesis.Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):14757-9. doi: 10.1073/pnas.261596398. Proc Natl Acad Sci U S A. 2001. PMID: 11752419 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
